ANGLE plc Total Assets
ANGLE plc total assets. Based on the latest financial reports, ANGLE plc (AGL) holds total assets worth GBX18.08 Million GBX (≈ $2.20K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ANGLE plc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of ANGLE plc (2001–2024)
Total assets of ANGLE plc from 2001 to 2024. This chart illustrates how ANGLE plc's total assets have evolved over time, based on quarterly financial data. See ANGLE plc stock quote for real-time trading data and today's change.
ANGLE plc - Asset Composition Analysis
ANGLE plc Total Assets Breakdown (December 2024)
ANGLE plc total assets breakdown as of December 2024. ANGLE plc's total assets of GBX18.08 Million consist of 64.5% current assets and 35.6% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 41.0% |
| Accounts Receivable | GBX1.80 Million | 7.1% |
| Inventory | GBX1.58 Million | 6.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX441.00K | 1.7% |
| Goodwill | GBX2.21 Million | 8.7% |
Asset Composition Trend (2001–2024)
This chart illustrates how ANGLE plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ANGLE plc (AGL) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ANGLE plc's current assets represent 64.5% of total assets in 2024, a decrease from 94.9% in 2001.
- Cash Position: Cash and equivalents constituted 41.0% of total assets in 2024, down from 60.1% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 8.7% of total assets.
ANGLE plc Competitors by Total Assets
Key competitors of ANGLE plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Vijaya Diagnostic Centre Limited
NSE:VIJAYA
|
India | Rs15.07 Billion |
|
ALPHAHELIX MOL.DIAGN. SK1
F:4MB
|
Germany | €18.96 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
ANGLE plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.13 | 5.19 | 8.72 |
| Quick Ratio | 2.63 | 4.80 | 8.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX6.72 Million | GBX19.07 Million | GBX29.15 Million |
ANGLE plc - Advanced Valuation Insights
This section examines the relationship between ANGLE plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.47 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -18.4% |
| Total Assets | GBX25.46 Million |
| Market Capitalization | $94.18K USD |
Valuation Analysis
Below Book Valuation: The market values ANGLE plc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: ANGLE plc's assets decreased by 18.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for ANGLE plc (2001–2024)
The table below shows the annual total assets of ANGLE plc from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX25.46 Million ≈ $3.10K |
-18.36% |
| 2023-12-31 | GBX31.18 Million ≈ $3.79K |
-37.47% |
| 2022-12-31 | GBX49.87 Million ≈ $6.07K |
+5.40% |
| 2021-12-31 | GBX47.31 Million ≈ $5.76K |
+21.17% |
| 2020-12-31 | GBX39.05 Million ≈ $4.75K |
+27.72% |
| 2019-12-31 | GBX30.57 Million ≈ $3.72K |
+32.82% |
| 2019-04-30 | GBX23.02 Million ≈ $2.80K |
+25.92% |
| 2018-04-30 | GBX18.28 Million ≈ $2.22K |
+67.45% |
| 2017-04-30 | GBX10.92 Million ≈ $1.33K |
+62.01% |
| 2016-04-30 | GBX6.74 Million ≈ $819.94 |
-39.94% |
| 2015-04-30 | GBX11.22 Million ≈ $1.37K |
+82.14% |
| 2014-04-30 | GBX6.16 Million ≈ $749.49 |
-18.12% |
| 2013-04-30 | GBX7.52 Million ≈ $915.31 |
+45.09% |
| 2012-04-30 | GBX5.18 Million ≈ $630.86 |
-1.31% |
| 2011-04-30 | GBX5.25 Million ≈ $639.26 |
-2.76% |
| 2010-04-30 | GBX5.40 Million ≈ $657.39 |
-0.86% |
| 2009-04-30 | GBX5.45 Million ≈ $663.11 |
-40.63% |
| 2008-04-30 | GBX9.18 Million ≈ $1.12K |
+18.57% |
| 2007-04-30 | GBX7.74 Million ≈ $941.98 |
-51.97% |
| 2006-04-30 | GBX16.12 Million ≈ $1.96K |
0.00% |
| 2005-04-30 | GBX16.12 Million ≈ $1.96K |
+33.68% |
| 2004-04-30 | GBX12.06 Million ≈ $1.47K |
+1049.57% |
| 2003-04-30 | GBX1.05 Million ≈ $127.63 |
-18.56% |
| 2002-04-30 | GBX1.29 Million ≈ $156.71 |
-22.32% |
| 2001-04-30 | GBX1.66 Million ≈ $201.73 |
-- |
About ANGLE plc
ANGLE plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis. It also provides Portrait+ C… Read more